REDCARE PHARMACY NV/ NL0012044747 /
2024-09-06 5:32:23 PM | Chg. -1.00 | Volume | Bid5:32:23 PM | Ask5:32:23 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
117.60EUR | -0.84% | 0 Turnover: - |
-Bid Size: - | -Ask Size: - | 2.29 bill.EUR | - | - |
Assets
|
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 2.6000 | 8.3000 | 11.9000 | 13.2000 | 74.5000 | ||||||
Intangible Assets | 22.2000 | 189.8000 | 199.9000 | 199.9000 | 204.7000 | ||||||
Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 2.5000 | 1.7000 | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | 18.8000 | 40 | 43.3000 | 56.7000 | 81.2000 | ||||||
Accounts Receivable | 8.3000 | 20.5000 | 34.6000 | 40.9000 | 44.6000 | ||||||
Cash and Cash Equivalents | 38.5000 | 15.8000 | 24.3000 | 62.7000 | 90.5000 | ||||||
Current Assets | 95.6000 | 95.4000 | 136.7000 | 210.8000 | 254.1000 | ||||||
Total Assets | 120.4000 | 297.8000 | 350.9000 | 428 | 536.9000 |
Liabilities
|
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 12.6000 | 23.1000 | 28.4000 | 32 | 53.1000 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 3 | 13 | 10.8000 | 3.9000 | 4.3000 | ||||||
Liabilities | 27.2000 | 58.8000 | 136.9000 | 195.2000 | 111.8000 | ||||||
Share Capital | - | - | - | - | - | ||||||
Total Equity | 93.2000 | 239 | 214 | 232.8000 | 425.1000 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 120.4000 | 297.8000 | 350.9000 | 428 | 536.9000 |
Income Statement
|
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 177.4000 | 284 | 539.7000 | 701 | 968.1000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -11.6000 | -19.2000 | -28.7000 | -33.4000 | -.9000 | ||||||
Interest Income | -9.2800 | -2.1600 | -5.9000 | -8.9000 | -15.1100 | ||||||
Income Before Taxes | -21 | -21.4000 | -34.6000 | -42.2000 | -15.9000 | ||||||
Income Taxes | -2.5000 | -.0500 | -1 | -5.9000 | .8000 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | -18.4000 | -21.4000 | -33.6000 | -36.3000 | -16.8000 |
Per Share
Cash Flow
|
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -17.2000 | -23.1000 | -23.5000 | -30.4000 | 17.8000 | ||||||
Cash Flow from Investing Activities | -24.5000 | -.9000 | -38.1000 | -33.4000 | -40.3000 | ||||||
Cash Flow from Financing | 76.6000 | -3.5000 | 65.3000 | 102.1000 | 50.3000 | ||||||
Decrease / Increase in Cash | 35 | -27.6000 | 3.6000 | 38.3000 | 27.8000 | ||||||
Employees | 349 | 483 | 843 | 1,011 | 1,220 |